'The race is on in this industry to take positions for future growth of probiotics.'

Probiotics giant buys world’s best-documented strain

By Shane STARLING contact

- Last updated on GMT

Some of the products LGG (Lactobacillus rhamnosus) features in. Chr Hansen has ambitions for much more. Image: ©Valio
Some of the products LGG (Lactobacillus rhamnosus) features in. Chr Hansen has ambitions for much more. Image: ©Valio

Related tags: Chr hansen, Probiotic

Danish probiotics and enzymes leader Chr Hansen has paid €73m in cash to acquire the Lactobacillus rhamnosus-based LGG suite of probiotic strains from Finnish dairy group, Valio.

Chr Hansen gains full rights on LGG including existing deals, a small production site in Tikkurila, Finland, plus other dairy-focused specialty strains and a library of 3200 strains.

Functional foods market expert and consultant, Peter Wennstrom, founder of the Healthy Marketing Team, said the move made sense as Chr Hansen sought to solidify its presence in probiotics.

"Chr Hansen has its roots in fermentation and not in probiotics as do firms like Probi and BioGaia and they are clearly moving forward in the value chain by securing a globally accepted strain portfolio,"​ Wennstrom told us. 

wennstrom
Peter Wennstrom

"Key now is for them to have probiotic strains that can be applied to their customers' portfolio and LGG thrives in both dairy and juice not to mention in supplements."

"The race is on in this industry to take positions for future growth of probiotics."

Chr Hansen and Valio already have a close business relationship; Chr Hansen manufactures the most LGG products – especially in infant formula and human nutrition and Valio CEO Annikka Hurme said collaboration between the firms would continue.

LGG has had more research performed on it than any other strain (over 200 studies mostly focused on gut and immune health, with 800 other references) and debuted in 1990 in Valio-owned Gefilus probiotic fruit juice drinks.

Chr Hansen CEO Cees de Jong said his firm would “capture the full potential of the LGG brand across markets for dietary supplements and infant formula offerings, as well as pursuing new opportunities in dairy.”

Chr Hansen’s marquee strain is BB-12 (Bifidobacterium Lactis​) which has been blended with LGG in the past by Chr Hansen in applications like powder sachet, Probio-Tec.

Valio shifts focus from ingredients to branded products

After publication, Ross Crittenden, Valio executive vice president for New Markets commented on the deal. "The sale will allow reallocation of resources from LGG ingredient sales to Valio's core business in branded consumer products. This includes continued development of Valio's probiotic range of Gefilus dairy and juice products that deliver the benefits of LGG in combination with great taste."  

Related news

Show more

Related products

show more

Know your Ethnic Dairy Opportunities

Know your Ethnic Dairy Opportunities

DuPont Nutrition & Health | 05-Dec-2018 | Technical / White Paper

Global consumers often look for something new from the yogurt category and products with a good story. In Western markets, this demand is driving a trend...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 19-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

GLOBAL PREFERENCES: TEXTURANTS PLAY A KEY ROLE.

GLOBAL PREFERENCES: TEXTURANTS PLAY A KEY ROLE.

Tate and Lyle | 16-May-2018 | Technical / White Paper

Texture is a matter of taste, and that’s true on a global scale as well. What appeals to consumers in Italy might turn off those in Indonesia. As formulators,...

Related suppliers

Follow us

Products

View more

Webinars